Accera Spins Off Neuera Pharmaceuticals
Broomfield, Colorado-based Accera, a developer of treatments for central nervous sytem diseases, said Wednesday that it has spun off a new firm, Neuera Pharmaceuticals, backed by $12M in a Series A financing round. According to Accera, Neuera will focus on the discovery and development of proprietary small molecule drugs, particularly around defective energy metabolism or hypometabolism. Accera said that some of its management and staff will join the new firm, and the firm's small molecule pipeline has been transferred to the new firm.
posted on Thursday, April 16, 2009
Related companies:
Accera
Related stories:
> Accera Gets $35M
> Accera Raises $7.5M
> Prolexys Pharmaceuticals Raises $20M
> Tolero Pharmaceuticals Finds $14.2M
> N30 Pharmaceuticals Names New CEO
Techrockies.com Home